SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.05-3.5%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (15230)5/10/2001 11:31:54 PM
From: Bluegreen   of 17367
 
That was the final straw for me. I was also disappointed that we didn't get a full explanation of Baysian effort by Xoma and Baxter. BTW, Crohn's indication is ONLY PHASE II!!!!!! Can you believe it???? How many years to market IF it is successful???? AND THAT IS IF NOTHING IS DELAYED MUCH LESS IF FAILURE LIKE HEMO TRAUMA TRIAL!!!!!!! Of course I am just sick to think of how the Meningo. trial was conducted. I was quick to blame the FDA BUT now I wonder. Hopefully Xanelim does not hiccup. Only my opinions.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News